Automotive Industry Grapples with Design Patent Obviousness: The Rosen-Durling Test Debated

The issue of design patent obviousness in the automotive industry has come under the spotlight recent times, particularly with the legal battle between LKQ Corp. and GM Global Technology Operations LLC. The case has reenergized discussions around the complex and often nebulous aspect of patent law. The central focus of the contention is the Rosen-Durling…

Read More

Navigating Intellectual Property and Privacy Challenges in the Generative AI Revolution

Artificial intelligence (AI) innovations have dramatically reshaped numerous industries over the past decade, with the media and entertainment sector being prominently influenced. Triggered by advances in generative AI (GenAI), novel tools have emerged, offering creative solutions that barely require human involvement. Legal professionals within this space need to keep abreast of these changes and the…

Read More

Safeguarding Attorney-Client Privilege Amid Generative AI Integration

While navigating the intersection of law and technology, legal professionals especially need to comprehend the opportunities and risks linked with new technological advancements. The ongoing incorporation of generative artificial intelligence (AI) tools into law practice is a clear example of such a context, where ensuring attorney-client privilege is crucial. The implications of these AI tools…

Read More

MedTech Patent Battle Escalates as Meril Challenges Edwards Lifesciences Heart Valve Patents

Indian medical device manufacturer Meril has lodged a challenge in court seeking to invalidate two patents currently safeguarding the design of prosthetic heart valves. These patents belong to Edwards Lifesciences, a company which has levelled infringement claims against Meril spanning five jurisdictions. Edwards Lifesciences, a known player in the MedTech business, owns patents that protect…

Read More

Navigating the First Financing Round: Key Insights for Biotech Startups

As the biotechnology sector continues to evolve, many biotech startups face the daunting prospect of their first financing round. The task, albeit challenging, can be managed effectively with the right preparation and strategy. In this context, Morgan Lewis’s day two treatise during the Biotech Week Boston provides key insights for such companies.The discussion particularly focuses…

Read More

Addressing Geopolitical Risks and Chinese Technical Collection at UNGA: Global Implications and Solutions

The geopolitical tension seems to be on the rise as the United Nations General Assembly (UNGA) holds its 78th annual gathering this week. The agenda holds a global resonance as top leaders and diplomats from across the world convene intending to address the most pressing international concerns. The concurrent forum necessitates a dialogue on non-traditional…

Read More

Federal Circuit Halts Judge Pauline Newman, Age 96, for Mental Fitness Concerns and Investigation Interference

Escalating concerns over the mental fitness of some older judges have led to a significant action in the Federal Circuit, as Judge Pauline Newman, 96, has been suspended. The suspension, effective immediately, prohibits Judge Newman from hearing any cases for the duration of one year. The decision comes after other active judges on the court…

Read More

Unraveling the Ties: Willingham’s Bold Move in Comic Intellectual Property Rights Battle

In a considerably unorthodox move within the comic industry, comics creator Bill Willingham has released his copyrights for one of his popular series into the public domain. His decision underscores a growing pressure faced by creators in recent years, as publishers increasingly expect them to relinquish influence over their intellectual property rights. This decision, described…

Read More

Merck Faces Criticism Over Challenge to Medicare Drug Price Negotiation Program

On Tuesday, Merck & Co. Inc. came under severe criticism from the AARP, Democratic lawmakers, and leading physician groups for its challenge to the Medicare drug price negotiation program. The critics dismissed Merck’s constitutional arguments, asserting that the pharmaceutical giant is attempting to undermine a program designed to enhance drug access and slash federal expenditure.Law360…

Read More

Takeda Seeks Early Termination of Gout Drug Antitrust Case Amid Trial

In a developing story, Takeda Pharmaceuticals has requested an early termination of a currently active antitrust legal proceeding. The multinational pharmaceutical company is under scrutiny with respect to delayed introduction of a generic adaptation of their gout medication — Colcrys. Takeda contends that the existing patent disputes and an absence of substantial evidence suggesting a…

Read More

Design Patent Precedent Revisited: Federal Appeals Circuit Sheds Light on Intellectual Property Disputes

The latest case report from the Federal Appeals Circuit, concerning Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., (Appeal Nos. 2021-2299, -2338) provides an illuminating analysis of precedent concerning design patents and infringement scope. Dated September 15, 2023, this decade-old case offers fresh insight into the domain of intellectual property law, particularly in…

Read More

Valeant Challenges Ninth Circuit Ruling Amid Whistleblower Law Dispute

Pharmaceutical firm Valeant, renowned for its bowel disease treatment, has recently disputed a Ninth Circuit ruling, arguing that the decision diverges from the precedents set by “at least eleven” other appeal courts. The contested ruling addressed whether disclosures from patent proceedings could be assembled to support a patent lawyer’s invocation of whistleblower laws. This came…

Read More